MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
{{output}}
Introduction: MET amplification is an important genetic alteration in NSCLC. Unlike in patients with EGFR and ALK alterations, the efficacy of immune checkpoint inhibitors in patients with MET-amplified NSCLC remains unknown. ... ...
